BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36305701)

  • 1. Oxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.
    Zager RA
    Physiol Rep; 2022 Oct; 10(20):e15507. PubMed ID: 36305701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury.
    Johnson ACM; Delrow JJ; Zager RA
    Transl Res; 2017 Aug; 186():1-18. PubMed ID: 28586635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NRF2 stimulating agent, tin protoporphyrin, activates protective cytokine pathways in healthy human subjects and in patients with chronic kidney disease.
    Zager RA; Johnson ACM
    Physiol Rep; 2020 Sep; 8(18):e14566. PubMed ID: 32940965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.
    Zager RA
    Transl Res; 2015 Nov; 166(5):485-501. PubMed ID: 26117289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and consequences of oxidant-induced renal preconditioning: an Nrf2-dependent, P21-independent, anti-senescence pathway.
    Johnson ACM; Zager RA
    Nephrol Dial Transplant; 2018 Nov; 33(11):1927-1941. PubMed ID: 29522116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pharmacologic "Stress Test" for Assessing Select Antioxidant Defenses in Patients with CKD.
    Zager RA; Johnson ACM; Guillem A; Keyser J; Singh B
    Clin J Am Soc Nephrol; 2020 May; 15(5):633-642. PubMed ID: 32291269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
    Zager RA; Johnson AC; Frostad KB
    Kidney Int; 2016 Jul; 90(1):67-76. PubMed ID: 27165818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenterial iron sucrose-induced renal preconditioning: differential ferritin heavy and light chain expression in plasma, urine, and internal organs.
    Johnson AC; Gooley T; Guillem A; Keyser J; Rasmussen H; Singh B; Zager RA
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1563-F1571. PubMed ID: 31608670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
    Zager RA; Johnson ACM; Therapeutics R
    Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.
    Liu Z; Gong R
    Am J Kidney Dis; 2015 Nov; 66(5):846-56. PubMed ID: 26271146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.
    Lamy A; Chertow GM; Jessen M; Collar A; Brown CD; Mack CA; Marzouk M; Scavo V; Washburn TB; Savage D; Smith J; Bennetts J; Assi R; Shults C; Arghami A; Butler J; Devereaux PJ; Zager R; Wang C; Snapinn S; Browne A; Rodriguez J; Ruiz S; Singh B;
    EClinicalMedicine; 2024 Feb; 68():102364. PubMed ID: 38586479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
    Uchida A; Kidokoro K; Sogawa Y; Itano S; Nagasu H; Satoh M; Sasaki T; Kashihara N
    Nephrology (Carlton); 2019 Jan; 24(1):28-38. PubMed ID: 29068550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning with tin-protoporphyrin IX attenuates ischemia/reperfusion injury in the rat kidney.
    Kaizu T; Tamaki T; Tanaka M; Uchida Y; Tsuchihashi S; Kawamura A; Kakita A
    Kidney Int; 2003 Apr; 63(4):1393-403. PubMed ID: 12631355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroacupuncture Ameliorates Acute Renal Injury in Lipopolysaccharide-Stimulated Rabbits via Induction of HO-1 through the PI3K/Akt/Nrf2 Pathways.
    Yu JB; Shi J; Zhang Y; Gong LR; Dong SA; Cao XS; Wu LL; Wu LN
    PLoS One; 2015; 10(11):e0141622. PubMed ID: 26524181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.
    Liu T; Fang Y; Liu S; Yu X; Zhang H; Liang M; Ding X
    Free Radic Biol Med; 2015 Apr; 81():170-82. PubMed ID: 25451640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Nrf2 in Protection Against Renal Disease.
    Guerrero-Hue M; Farre-Alins V; Palomino-Antolin A; Parada E; Rubio-Navarro A; Egido J; Egea J; Moreno JA
    Curr Med Chem; 2017; 24(33):3583-3605. PubMed ID: 28494744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic postconditioning attenuates acute kidney injury following intestinal ischemia-reperfusion through Nrf2-regulated autophagy, anti-oxidation, and anti-inflammation in mice.
    Chen R; Zeng Z; Zhang YY; Cao C; Liu HM; Li W; Wu Y; Xia ZY; Ma D; Meng QT
    FASEB J; 2020 Jul; 34(7):8887-8901. PubMed ID: 32519766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.